Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Long Term Debt
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mainz Biomed N.V (MYNZ) Finished Goods: 2023-2024

  • Mainz Biomed N.V's Finished Goods was N/A to $178,810 in Q2 2024 from the same period last year, while for Jun 2024 it was $178,810, marking a year-over-year change of. This contributed to the annual value of $240,467 for FY2023, which is N/A change from last year.
  • Per Mainz Biomed N.V's latest filing, its Finished Goods stood at $178,810 for Q2 2024, which was down 25.64% from $240,467 recorded in Q4 2023.
  • Over the past 5 years, Mainz Biomed N.V's Finished Goods peaked at $240,467 during Q4 2023, and registered a low of $175,799 during Q3 2023.
  • In the last 2 years, Mainz Biomed N.V's Finished Goods had a median value of $178,810 in 2024 and averaged $198,359.